d1a5 2-farjana mahammed gsk · 2018-06-14 · our process implements new technology, whilst...

18
Hui Process scientist China Small & Fast How to improve bioanalytical throughput whilst maintaining/improving quality Farjana Mahammed EBF 10 th Open Meeting: 10 - A New Journey begins

Upload: others

Post on 10-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

HuiProcess scientistChina

Small & FastHow to improve bioanalytical throughput whilst maintaining/improving quality

Farjana MahammedEBF 10th Open Meeting: 10 - A New Journey begins

Page 2: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

Today’s World…‘Do More, With Less?’

2

Bioanalysis

High Throughput

(HT)

Quality of Data

The Bioanalytical World.. § Pre-clinicaldrugdevelopmentisbothatimelyandcostlyprocess,leadingtofocusedeffortsonshrinkingthebudgetandimprovingR&Defficiency

§ Continuouslyevaluatingproductivityandprocess,§ Peopleandinstrumentation§ Streamlineandsimplifytheprocess

How can we implement new technology to improve throughput? Whilst maintaining a MATCH between QUALITY and THROUGHPUT

The Social World.. § Areconstantlyembracingnewpeople&experiences

§ ‘Swipingright’tofindtheirtruematch..

tinder

Page 3: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

3

Our ProcessEmbracing New Technologies

Less Steps (Automation)

Method Development

Wet lab sample

preparationLC-MS/MS

Method Data analysis

§ Rapid discovery quantitation§ Gradients from minutes to

seconds, whilst retaining proportionate peak separation

§ Decrease attrition in the portfolio

§ Understanding interfering signals can prevent over-quantification of the drug

Less Surprises (Isobaric)Less Time (RapidSep)

Succeedinginhigh-throughput(HT)methoddevelopmentandsampleanalysis,withlesspeople,reducesthetimetakentomovetotheclinic

Review Bottlenecks

Seek Automation

SolutionEvaluate

Embed

Page 4: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

…‘Swipe Right!’

4

Bioanalysis

Swipe right

BioanalysisBioanalysisHP D300e Digital Dispenser Agilent Bravo Automated Liquid Handling Platform

Page 5: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

5

HP D300e Digital DispenserNew Picolitre Dispensing Technology

§ Assay miniaturization

§ Decreasing solvent consumption

§ Pipette directly into dispense head cassettes

§ T8 : 20 uL limit

§ T4 : 200 uL limit§ Highly intuitive and easy-to-program software

for simple to complex assays§ Minimise drug titration time§ Increase productivity

Bioanalysis

Better

Bioanalysis

Faster

Bioanalysis

Easier

Page 6: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

6

HP D300e Digital DispenserWorkflow of manual line preparation Vs. D300e line preparation

2 mins

• Prepare working solutions in 50:50 ACN:H2O by serially diluting the stocks

15 mins

• Follow spiking scheme to create calibration line in Eppendorfs®

5 mins• Sub aliquot 50µl from

Eppendorfs® into tubes

3 mins• Precipitate proteins with

acetonitrile to remove impurities

5 mins• Centrifuge at 3000g and

remove clean supernatant

2 mins• Pipette 50µl control matrix

into tubes

30 secs

• Place stock solution on D300e and set to create calibration line

3 mins• Precipitate proteins with

acetonitrile to remove impurities

5 mins• Centrifuge at 3000g and

remove clean supernatant

5 mins

Manual Calibration Line D300e Calibration Line

Page 7: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

7

TroubleshootingEvaluating the dispensing capability of the D300e

0

100000

200000

300000

400000

500000

600000

700000

800000

900000

1000000

0 2000 4000 6000 8000 10000

Anal

yte

Peak

Are

a (c

ount

s)

Analyte Concentration (ng/ml)

200pl

100pl

50pl

Manual

Decreasing Dispense Volumes

0

0.2

0.4

0.6

0.8

1

1.2

1.4

1.6

1.8

2

0 2000 4000 6000 8000 10000

Peak

Are

a R

atio

Analyte Concentration (ng/ml)

100% DMF

20% DMF

10% DMF

5% DMF

Manual

DMF Dispensing Capability

0

0.5

1

1.5

2

2.5

3

3.5

0 1000 2000 3000 4000 5000

Peak

Are

a R

atio

Analyte Concentration (ng/ml)

D300eManual

D300e and Manual Calibration Line Comparison With Matrix

Page 8: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

To Regulated Validation…Benefits

8

0

2

4

6

8

10

12

14

16

0 2000 4000 6000 8000 10000

Peak

Are

a R

atio

Analyte Concentration (ng/ml)

Manual

D300e

D300e and Manual Calibration Line For A Validated Method

BioanalysisBioanalysis

Calibration?à Determine if it

is possible to calibrate the

instrument for use in GLP studies

BioanalysisBioanalysis

Accurately dispenses

down to 50plà This is fit for

purpose à Can it

accurately dispense lower?

BioanalysisBioanalysis

Capable of dispensing DMF stocks diluted

into DMSOà Highly beneficial

for practical and safety implications

r = 0.9989

r = 0.9963

Page 9: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

9

Agilent BravoWorkflow

‘Providing speed and precision on your benchtop’

Pipette control matrix into

tubes

Prepare STDs/QCs

Vortex

Sub-Aliquot STDs, QCs & Samples

Dispense I.S. Crash solution to all tubes

Vortex Centrifuge

Supernatant Transfer

Inject on LC-MS/MS

Page 10: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

…‘It’s A Match!’

10

Bioanalysis

Understanding Isobaric

Interferences

Decrease Attrition

Page 11: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

11

Isobaric InterferencesBackground

What? Why?§ Common interferences observed in LC-MS/MS analyses caused by the response of

drug-related metabolites to the MRM channel of a given drug, as a result of in-source reactions or decomposition of either phase I or II metabolites.

§ Can potentially interfere with the quantification of the parent molecule if they co-elute under the same chromatographic conditions

Formula change

Mass Shift (Da)

Phase I

Hydroxylation + Dehydration, Primary/secondary alcohol to aldehyde/Ketone, desaturation

- H2 -2

Oxidative defluorination -F + OH - 2

Oxidative deamination to ketone -NH3+ -1 - 1

Demethylation + oxidation to carboxylic acid 0

Phase II (possible in source dissociation back to parent)

Glucuronidation +C6H8O7 +176

Sulphation +SO4 +80

Common Phase I & II Drug Metabolites

Page 12: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

Precursor Ion Scan Neutral Loss Scan

12

What To Monitor?Key Scans

§ Spectrum of all parent ions which have the same product ion in their spectrum

§ Are the precursors identified the same mass as your parent or your metabolite?

§ Spectrum of all parent ions which lose a selected neutral loss fragment

Q1 Q2 Q3From

Column

SOURCE

SCAN FRAGMENT m/z SET

Q1 Q2 Q3From

Column

SOURCE

SCAN FRAGMENT OFFSET BY CHOSEN NL

Page 13: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

13

Our ProcessIn Silico predictions to In Vivo samples

To Know Beforehand:§ Molecule structure§ MW§ Product ion mass § Potential metabolites & masses

Request in silico predictions - Assess results for potential isobaric concerns

Set up appropriate MRM, precursor and neutral loss scans on

MS

Inject high dosed sample on a generic 2

minute Non-GLP gradient

Check that parent is observed in the

relevant precursor and neutral loss

scans

Extract chromatograms to check for isobaric

peaks

If isobaric peaks are detected, ensure

they are separated from parent or

investigate impact of co-elution

contribution i.e. < 1%

Page 14: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

…‘It’s A Match!’

14

Bioanalysis

Small&

Fast

BioanalysisBioanalysis

Page 15: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

15

RapidSep‘Minutes To Seconds’

RapidSep offers the potential for sub-30 second run timesAll things being equal, a faster run time is always going to be advantageous for Bioanalysis

Short (1x10mm, 5µm) column attached directly to MS source§ Enables fast gradients (30secs cycle times) producing ultra

sharp/narrow peaks whilst retaining proportionate peak separation.

Quicker Runsà Increase efficiency

Coupled to suitable automation à Better quality workflows

Retain acceptable performance à Chromatographic separationà Assay sensitivityà A & P

Page 16: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

16

To Regulated Validation…Comparison

NominalConc (ng/mL)

Mean (ng/mL)

SD %CV Accuracy (%)

3 2.7 0.2 7.22 91.4

9 8.6 0.3 3.93 95.7

80 81.0 5.5 6.74 101.3

800 756.3 42.4 5.61 94.6

1000 914.5 29.4 3.22 91.5

NominalConc (ng/mL)

Mean (ng/mL)

SD %CV Accuracy (%)

3 2.8 0.2 8.63 92.9

9 8.6 0.5 6.00 95.2

80 79.9 5.5 6.92 99.9

800 771.4 36.4 4.71 96.4

1000 898.0 24.9 2.77 89.8

Generic C18 Column(Std 300 ng/mL)

(2.52mins / 151secs)

17secs

RapidSep Column(Std 300 ng/mL)

Page 17: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

Summary & Conclusion

There is importance for the industry in starting from improving the non-GLP pre-clinical area– Unlocking New Technologies

§ Embedding Automation § Screening more samples in less time§ Fit for purpose methods

‘Do More, With Less?’

17

Preliminary in vivo animal safety assessments aimed at Go/No-Go decisions, all determine the plausibility of selecting one compound in becoming a safe and efficacious drug

§ Performing isobaric checks as early as possible

Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT

Page 18: D1A5 2-Farjana Mahammed GSK · 2018-06-14 · Our process implements new technology, whilst maintaining a MATCH between QUALITY and THROUGHPUT. Acknowledgements Thank you for listening

Acknowledgements

Thank you for listening

Scott Summerfield, Matthew Barfield, Adam Hughes, Teresa Heslop, Gabrielle Turvey, Arun Sen